Risk Assessment & Genetic Testing for Hereditary Cancer Susceptibility | Mollie Hutton, MS, CGC
Certified Genetic Counselor Mollie Hutton, MS, CGC, specializes in risk assessment and genetic testing for hereditary cancer risk. In this video, Mollie highlights ...
Roswell Park Comprehensive Cancer Center
Basics of Hereditary Breast Cancer
... of Health Research and Policy, Director of Women's Clinical Cancer Genetics Program at Stanford University School of Medicine discusses breast cancer risk ...
facingourrisk
Breast Cancer Q & A: How to Lower Your Risk for Breast Cancer (extended version)
HealthONE
High Risk Surveillance for Breast Cancer, February 22, 2012
facingourrisk
Overestimation of Benefit
In previous episodes of Healthcare Triage, we've discussed how people often misunderstand risk and how it affects them. We've also talked about how you can ...
Healthcare Triage
Understanding Genetic Testing for Breast Cancer with Dr. Nicholette Erickson
Understanding Genetic Testing for Breast Cancer with Dr. Nicholette Erickson.
Central Maine Healthcare
Misunderstandings about cancer risk factors - ESMO 2012
The opinion expressed in this interview reflects that of the interviewee and does not necessarily express the official ESMO point of view. Video produced by the ...
European Society for Medical Oncology
Live CMB | Manejo de pacientes com risco moderado.
Como interpretar o risco poligênico? ... CONVIDADOS: • Dr. André Mattar - Mastologista, Doutor pela Universidade Federal de São Paulo e Diretor do núcleo de ...
Câncer de Mama Brasil
Understanding Breast Cancer Biology: New Discoveries and Treatments
Stanford University breast cancer specialist Mark Pegram, MD, gives an update on the development of new therapeutics and the role of clinical trials in ...
Stanford Health Care
Copy Number Alterations and Breast Cancer
Retrospective Results From Archived FFPE Based on Oncoscan Solution Use of Oncoscan FFPE Assay and Molecular Inversion Probe analysis of copy number ...
Affymetrix
25 years after BRCA discovery: History, enigma, and lessons for the future - Pr David Goldgar
Pr David Goldgar traces the history and lessons learned from past and ongoing researches on breast and ovarian cancer susceptibility genes. David Goldgar ...
Institut Curie
Population Genetic Testing with Professor Ranjit Manchanda
If you missed our webinar on Population Genetic Testing in September 2020 you can catch up here. Watch and learn all about Population genetic testing: The ...
Ovarian Cancer Action UK
Breast Cancer and Oral Cancer Statistics
IISc Bangalore July 2018
Professor Peter Donnelley - Using Genomics to understan an individual's risk for common diseases
Filmed at the UK Biobank Scientific Conference in June 19.
UK Biobank
The Integration of ENCODE Into the Study of the Complexity of Cancer Susceptibility - S. Chanock
June 29 - July 1, 2015 -- ENCODE 2015: Research Applications and Users Meeting More: http://www.genome.gov/27561910.
National Human Genome Research Institute
ICAHO19 - Breast cancer session: Sequencing therapies in metastatic breast cancer
Dr. Mark Pegram, a breast oncologist from Stanford School of Medicine speaks on management approach for breast cancer at the 7th International Conference ...
Binaytara Foundation
9. Genetic Risk Factors | Mini Med School
(November 29, 2011) Thomas Quertermous explores how genetics influence cardiovascular diseases and how much risk heritability presents as opposed to ...
Stanford
Node-Negative Breast Cancer: A New Look
Lecture by Nadia Harbeck, MD Node-negative breast cancer is a prevalent form of the disease worldwide, particularly in regions with rigorous screening and ...
The Society for Translational Oncology
Little Company of Mary Comprehensive Breast Cancer Center Tumor Board
Panel discussion with the expert physicians Tumor Board Meeting of the Comprehensive Breast Cancer Center at Little Company of Mary.
LittleCompanyofMary
Breast Density: What is It and Why Does It Matter?
The PA Breast Cancer Coalition's latest webinar, "Breast Density: What is It and Why Does it Matter?" is now available online! Thank you to our expert presenter, ...
PABreastCancer
Risk of Postsurgical Disease Recurrence in RCC
Panelists Robert A. Figlin, MD; Sandy Srinivas, MD; Thai H. Ho, MD, PhD; and Martin H. Voss, MD, share their thoughts regarding risk assessment for predicting ...
OncLiveTV
GM XII Discussion: Risk prediction with and without genomics
On May 6-7, 2019, the National Human Genome Research Institute (NHGRI) sponsored its 12th Genomic Medicine meeting: Genomic Medicine XII: Genomics ...
National Human Genome Research Institute
Concept Clearance: eMERGE: Comprehensive Genomic Risk Assessment and Management - Teri Manolio
Full Title: Concept Clearance: Electronic Medical Records and Genomics (eMERGE): Comprehensive Genomic Risk Assessment and Management February 11 ...
National Human Genome Research Institute
Breast Cancer Screening by Megan McNamara
Grand Rounds presentation at Case Western Reserve University School of Medicine Department of Medicine on breast cancer screening by Megan McNamara, ...
CWRU Medicine
Federico Canzian - Genetic susceptibility to pancreatic cancer
Federico Canzian (Heidelberg, Germany) - Genetic susceptibility to pancreatic cancer 3rd Annual Meeting of the Hungarian Pancreatic Study Group 21 ...
Hungarian Pancreatic Study Group
2018.06.26-27 BIG DATA in Health Sciences - 陳秀熙教授
Session 9: Disease Screening and Surveillance 主持人：邱弘毅教授/台北醫學大學公共衛生學系講題：Stochastic Process for Disease Screening and Surveillance ...
國家衛生研究院 NHRI_Video
Chemical Mixtures Cancer
To conclude, Dr. Nicole Niehoff presented results from her study on airborne mammary carcinogens and breast cancer risk. In this research, Dr. Niehoff ...
Collaborative on Health and the Environment
Genetic Research and Bioinformatics in Cancer: A Dialog
Eric Perakslis, Ph.D. Kim Hirshfield, M.D., Ph.D. Jana Pruski-Clark, M.P.H., M.S..
CancerInstNJ
Kerala Psc Special Points Video Part-3/Staff Nurse/JHI Exam Special/Important/Nurse Queen
Kerala Psc Special Points Video Part-3/Staff Nurse/JHI Exam Special/Important/Nurse Queen Please Like our face book page ...
NURSE QUEEN
Mammatyper | Oncomet Technology.
Innovation in breast cancer diagnosis. Molecular in vitro diagnostic test for the quantitative detection of the mRNA expression of ERBB2, ESR1, PGR and MKI67 ...
Metropolis Lab
Management of High-Risk Prostate Cancer
Management of High-Risk Prostate Cancer by Adam Kibel, MD, Professor of Urology and Genetics, Washington University School of Medicine.
UBC Urology Rounds
DocTalks: Dr. Muriel Brackstone - What the Future of Breast Cancer Treatment Looks Like
Dr. Muriel Brackstone is the Medical Director of the Breast Care Program at St. Joseph's Hospital. In this lecture she shares how personalized medicine is ...
St. Joseph's Health Care London
2nd Annual Tatar Cancer Symposium 2012 - Dr McGuire
Kandace McGuire, MD Program Director of the Breast Surgical Ongology Fellowship Program, Director of Pre-menopausal Services, McGee Women's Hospital ...
Kettering Health Network
Novel Clinical Trials for Patients with Dense Breasts - Judy Garber, MD, MPH
... for Cancer Genetics and Prevention at Dana-Farber Cancer Institute, discusses the importance of ongoing research to learn more about breast cancer risk and ...
Brigham And Women's Hospital
Michael Farrell: Hereditary predisposition to ovarian cancer
OvaCare
Preventing Cancer and Chronic Disease - December 5, 2018
Providence California
E02.2 Prostate Cancer Predisposition: Implications for Early Detection and Treatment
Peter Nelson; Seattle, United States.
European Society of Human Genetics
Risk assessment of late recurrence (Ivana Sestak, UK)
Risk assessment of late recurrence (Ivana Sestak, UK) Recorded Thursday, March 21 at the 16th St. Gallen International Breast Cancer Conference Primary ...
Oncoletter
Developing and Applying Polygenic Risk Prediction Models for Precision Prevention - FULL LECTURE
Nilanjan Chatterjee, PhD Bloomberg Distinguished Professor Department of Biostatistics Department of Oncology Johns Hopkins University School of Medicine ...
JHSPH Deans Lectures
Hereditary Gynecological Cancer / Role of Prophylactic Procedure Dr. Mohammad Al Garni
5th Meeting masterclass for Gynecologic malignancies.
POCR oncology
2010 SABCS Interview with Amelie G. Ramirez, Dr.P.H.
Interview with Amelie G. Ramirez, Dr.P.H., director of the Institute for Health Promotion Research and professor of epidemiology and biostatistics at the University ...
American Association for Cancer Research
GENÉTICA EN CÁNCER SMEO 2020
38 CONGRESO NACIONAL DE ONCOLOGÍA HÍBRIDO-VIRTUAL 2020 GENÉTICA EN CÁNCER.
SMeO Sociedad Mexicana de Oncología
